医学
伊布替尼
原发性中枢神经系统淋巴瘤
淋巴瘤
肿瘤科
内科学
白血病
慢性淋巴细胞白血病
作者
Carole Soussain,Maxime Denis,Sylvain Choquet,Hervé Ghesquières,Caroline Houillier
标识
DOI:10.1016/j.ejca.2023.04.025
摘要
To the Editor, Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) networkEuropean Journal of CancerVol. 117PreviewPrimary central nervous system lymphomas (PCNSLs) are mainly diffuse large B-cell lymphomas (DLBCLs) of the non-germinal centre B-cell subtype, with unmet medical needs. This study aimed to evaluate the efficacy and toxicity of ibrutinib in DLBCL-PCNSL Full-Text PDF
科研通智能强力驱动
Strongly Powered by AbleSci AI